对于和硫末的机械洞察和药理方法及其作为治疗剂的含义
Madison Owens1, Anita Thyagarajan1, Jeffrey B Travers1,2,3
1Department of Pharmacology and Toxicology, Boonshoft School of Medicine, Wright State University, Dayton, Ohio, USA.
Journal of applied toxicology : JAT
|March 4, 2025
概括
和硫末是有毒的水泡剂,造成公共卫生问题. 了解它们的化剂机制对于开发新的癌症治疗方法和公共卫生战略至关重要.
科学领域:
- 毒理学 毒理学 毒理学
- 在瘤学瘤学.
- 公共卫生 公共卫生
背景情况:
- 和硫是带有严重公共卫生后果的水泡剂,特别是皮肤暴露.
- 有限的治疗选择需要更深入地了解囊泡剂毒性机制.
- 子剂,像化疗一样,作为化剂,调解细胞毒性活动.
研究的目的:
- 审查和硫毒性的机制.
- 探索减轻末诱导影响的策略.
- 评估末剂对抗多发性疾病的治疗潜力.
主要方法:
- 关于和硫末的现有研究的文献综述.
- 对黄化剂毒性的化剂机制的分析.
- 探索潜在的预防和治疗应用.
主要成果:
- 末剂主要通过化产生毒性.
- 了解这些机制可以为制定对策提供信息.
- 末剂显示出作为抗瘤剂的使用潜力.
结论:
- 对子剂机制的进一步研究对于公共卫生和癌症治疗至关重要.
- 利用它们的化特性可能会导致新的癌症治疗方法.
- 需要提高对子剂影响的认识,以减轻不良事件.
相关概念视频
Peptic Ulcer Disease IV: Management
58
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
58
2° Amines to N-Nitrosamines: Reaction with NaNO2
4.0K
Secondary amines react with nitrous acid to form N-nitrosamines, as depicted in Figure 1. Nitrous acid, a weak and unstable acid, is formed in situ from an aqueous solution of sodium nitrite and strong acids, such as hydrochloric acid or sulfuric acid, in cold conditions. In the presence of an acid, the nitrous acid gets protonated. The subsequent loss of water results in the formation of the electrophile known as nitrosonium ion.
4.0K
Structure-Activity Relationships and Drug Design
480
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
480
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Inflammatory Bowel Disease IV: Pharmacological Management
88
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
88
Preparation of Amines: Reduction of Oximes and Nitro Compounds
3.3K
Oximes can be reduced to primary amines using catalytic hydrogenation, hydride reduction, or sodium metal reduction. The reduction of aliphatic and aromatic nitro compounds to primary amines takes place by either catalytic hydrogenation or by using active metals like Fe, Zn, and Sn in the presence of an acid.
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
Though catalytic hydrogenation can reduce nitrobenzenes, the reduction is nonselective in the presence of other functional groups. For instance, if nitrobenzene contains an aldehyde group,...
3.3K


